More from Curaleaf

Multiple Sclerosis

Multiple sclerosis (MS) is an autoimmune condition caused by the body’s immune system attacking itself. This causes patches of inflammation in the brain and/or spinal cord.

It is characterised according to the progression of disease where symptoms may come and go (relapsing) or there is progressive worsening of symptoms with acute flare-up (progressive).

MS affects around 1 in 600 people in the UK.

Multiple Sclerosis Treatment

There is no cure currently for MS, therefore treatment aims to slow progression of disease, treat relapses and improve symptoms.

Medications that aim to slow disease progression are immunosuppressant medications (e.g. teriflunomide, interferon-β) that are started in a specialist setting.

Relapses are treated with a short course of corticosteroids.

Symptomatic management is usually aimed to reduce symptoms of spasticity, bladder dysfunction, and pain.

Sativex® (nabiximols), a medicinal cannabis product, is a licensed treatment for MS-related spasticity in the UK.

Other medicinal cannabis products can be considered when first line therapies have not achieved adequate benefit in improving symptomatic management.